** = Publikationen gelistet in SCI/SSCI/Pubmed
** Linortner, P; Fazekas, F; Schmidt, R; Ropele, S; Pendl, B; Petrovic, K; Loitfelder, M; Neuper, C; Enzinger, C
White matter hyperintensities alter functional organization of the motor system.
NEUROBIOL AGING. 2012; 33(1): 197.e1-197.e9.
Doi: 10.1016/j.neurobiolaging.2010.06.005
Web of Science
PubMed
FullText
FullText_MUG
** Enzinger, C; Jehna, M; Langkammer, C; Linortner, P; Aspeck, E; Pendl, B; Gattringer, T; Petrovic, K; Ropele, S; Fazekas, F
No evidence for increased iron deposition in deep gray matter regions in subjects with MRI findings suggestive of cerebral small vessel disease
J NEUROL. 2011; 258: 11-11.
[Oral Communication]
Web of Science
** Fazekas, F; Linortner, P; Schmidt, R; Ropele, S; Pendl, B; Petrovic, K; Neuper, C; Enzinger, C
fMRI evidence for an effect of white-matter hyperintensities on the functional organization of the motor system with ageing
J NEUROL. 2010; 257: O117 -20th Meeting of the European Neurological Society; JUNE 19-12, 2010; Berlin, GERMANY.
[Oral Communication]
Web of Science
** Schmidt, R; Ropele, S; Pendl, B; Ofner, P; Enzinger, C; Schmidt, H; Berghold, A; Windisch, M; Kolassa, H; Fazekas, F
Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine.
J Neurol Neurosurg Psychiatry. 2008; 79(12): 1312-1317.
Doi: 10.1136/jnnp.2007.141648
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fazekas, F; Ropele, S; Ebenbauer, B; Windisch, M; Stöffler, A; Schmidt, R
The effects of memantine in Alzheimer's disease patients: a randomised, double-blind, placebo-controlled pilot study exploring the contribution of multimodal neuroimaging.
J NEUROL. 2007; 254: 43-43.-17th Meeting of the European Neurological Society (ENS); JUN 16-20, 2007; Rhodes, GREECE.
[Oral Communication]
Web of Science
** Schmidt, R; Ropele, S; Ebenbauer, B; Windisch, M; Stoeffler, A; Fazekas, F
A pilot neuroimaging study evaluating effects of memantine on brain volume, glucose metabolism and cognition a randomised, double-blind, placebo controlled design in Alzheimer's disease
EUR J NEUROLOGY. 2007; 14: 293-294.-7th Meeting of the European Neurological Society; JUN 16-20, 2007; Rhodes, GREECE.
[Oral Communication]
Web of Science
** Ropele, S; Gorani, F; Pendl, B; Enzinger, C; Seewann, A; Schmidt, R; Fazekas, F
A longitudinal MTR study in mild to severe Alzheimer's disease
J NEUROL 2005 252: 44-44.
Web of Science